BPC 157 resolves neuronal damage and prevents memory, locomotor, and coordination deficits
Additionally, rectal administration can result in higher bioavailability and faster onset of action compared to some other routes, as the medication bypasses the first-pass metabolism in the liver
The addition of GIP activation clearly enhanced metabolic outcomes compared to GLP-1 alone
The LR3 extension does not make it "safer" -- it makes it longer-acting and less regulated by binding proteins, which from a risk standpoint means sustained free IGF-1R activation without the IGFBP buffering system that modulates native IGF-1 activity in healthy physiology
Importantly, such degradation can occur without any visible change to the solution a medicine may appear normal whilst having lost potency
Passarelli, S., Free, C.M., Shepon, A., Beal, T., Batis, C., Golden, C.D., 2024